Table 1.

Oral mucositis assessment in clinical practice.

	Clinical setting
	Standard chemotherapywhere risk of OM is >20%	Head and neck (chemo)radiotherapy	HSCT	Targeted agents	Immunotherapy
Recommended tool for clinician assessment	WHO	WHO	WHO	No consensus	No consensus
Frequency of assessment	Weekly and every time the symptoms manifest. Televisit/telehealth may complement this assessment	Weekly or more in high grade mucositis	Daily (if inpatient) Weekly (if feasible in outpatient setting)	As the trajectories vary, assessment should be performed at least at each cycle or clinic visit/telehealth appointment	At each cycle or clinic visit/telehealth appointment
Recommended PROM	OMWQ or PRO-CTCAE questions related to mucositis	OMWQ and OMDQ or PRO-CTCAE questions related to mucositis	OMWQ or OMDQ or PRO-CTCAE questions related to mucositis	No consensus	No consensus
Frequency of assessment	Weekly or whenever present with symptoms	Weekly or more frequently in severe mucositis	Weekly or whenever present with symptoms	At each cycle or clinic visit/telehealth appointment	At each cycle or clinic visit/telehealth appointment
Biomarkers to consider	No biomarkers recommended	No biomarkers recommended	No biomarkers recommended	No biomarkers recommended	No biomarkers recommended